Please assess the completion status of the following clinical trial:

Trial Title: Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Provision of signed and dated informed consent form (ICF)~2. Male or female, aged 20 to 80 years inclusive at the time of signing ICF~3. French-speaking~4. reliable informant~   Controls:~5. derived from the general population and consenting to participate in the study~   Patients:~6. MMS\>18~7. Patients followed for mild or major neurocognitive disorder related to :~   * Alzheimer's disease~  * Frontotemporal lobar degeneration~  * Lewy bodies disease~  * Parkinson's disease~  * Huntington's disease~  * Progressive supranuclear palsy~  * traumatic brain injury~  * stroke or cerebral anoxia~  * mixed diseases~  * focal cerebral diseases~Exclusion Criteria:~1. Illiteracy~2. mental retardation~3. visual or motor deficit preventing reading, drawing or writing (scores on the reading, drawing or sentence writing subtests of the MMSE = 0)~4. hearing impairment interfering with understanding of instructions,~5. history of brain disease, including head injury with loss of consciousness lasting \> 15 minutes, stroke, coma or loss of consciousness lasting \> 15 minutes, followed for sclerosis or other brain disease, brain radiation therapy, epilepsy currently requiring treatment~6. history of psychiatric illness (schizophrenia or other psychosis) or ongoing psychiatric illness (major depressive disorder or other condition) currently requiring treatment or requiring a stay \> 2 days in a psychiatry unit or anxiety requiring more than one medication at the present time~7. alcoholism (mean alcohol consumption \> 3 standard drinks/day or history of alcohol withdrawal)~8. use of opiates or other illicit drugs during the previous 3 months or causing withdrawal syndrome~9. ongoing antidepressant or antiepileptic treatment~10. anxiolytic or hypnotic treatment initiated or increased during the previous month~11. general anaesthesia during the previous 3 months~12. history of heart surgery with cardiopulmonary bypass~13. comorbidities affecting cognition (respiratory, renal, liver, heart failure...)~14. women of childbearing potential (defined as pre-menopausal, less than 2 years postmenopausal, or not surgically sterile)~15. persons placed under judicial protection~    Patients :~16. contraindication to MRI~    Controls:~17. deficit on MMSE \<27

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 80 Years
- Healthy Volunteers: t

Study Arms:
- Patients (Type: ACTIVE_COMPARATOR): battery of tests of social cognition
- Control (Type: ACTIVE_COMPARATOR): battery of tests of social cognition

Based on this trial design, predict the completion outcome and termination type (if applicable).